Cantitate/Preț
Produs

Reverse Pharmacology: Phytocannabinoids, Banned and Restricted Herbals

Autor Amritpal Singh Saroya
en Limba Engleză Hardback – 26 apr 2018
Reverse Pharmacology: Phytocannabinoids, Banned and Restricted Herbals will serve as a tailormade reference guide for the manufacturers and practitioners of herbal drugs. Part A deals with Reverse Pharmacology & Nanophytomedicine and Part B with Phytocannabinoids and description of banned or restricted herbal drugs. Part B also includes chemical structures and unpublished material which are the salient features of this book. The work is an invaluable resource for professionals in the manufacturing of herbal and pharmaceutical products as well as those persons in regulatory affairs.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 31016 lei  6-8 săpt.
  CRC Press – 31 mar 2021 31016 lei  6-8 săpt.
Hardback (1) 98243 lei  6-8 săpt.
  CRC Press – 26 apr 2018 98243 lei  6-8 săpt.

Preț: 98243 lei

Preț vechi: 132955 lei
-26% Nou

Puncte Express: 1474

Preț estimativ în valută:
18800 19773$ 15709£

Carte tipărită la comandă

Livrare economică 09-23 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781138037076
ISBN-10: 1138037079
Pagini: 218
Ilustrații: 2 Tables, black and white; 4 Illustrations, color; 317 Illustrations, black and white
Dimensiuni: 156 x 234 x 18 mm
Greutate: 0.52 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States

Cuprins

Introduction to Herbal/Phytomedicine. Regulatory requirements of Herbal Drugs. Herbal drug toxicity. US FDA and Herbal Drugs. A-Z of Banned and restricted herbal drugs. A-Z of Red Listed herbal plants.

Descriere

This book serves as a reference guide for manufacturers and practitioners of herbal drugs. It is divided into two parts to differentiate between herbal drugs that are banned or restricted and herbal plants that are red listed. It is an invaluable resource to professionals in the herbal and pharmaceutical trades and in regulatory drug production.